Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: Results of the 2008-12 National Health Examination Survey

Nephrology Dialysis Transplantation

Volumn 30, Issue 5, 2015, Pages 806-814

  De Nicola, Luca ^a,b   Donfrancesco, Chiara ^c   Minutolo, Roberto ^a,b   Lo Noce, Cinzia ^c   Palmieri, Luigi ^c   De Curtis, Amalia ^d   Iacoviello, Licia ^d   Zoccali, Carmine ^a,e   Gesualdo, Loreto ^a,f   Conte, Giuseppe ^a,b   Vanuzzo, Diego ^g,h   Giampaoli, Simona ^c  

^a Italian Society of Nephrology   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d IRCCS NEUROMED   (Italy)

^e Center of National Research Institute of Biomedicine and Molecular Immunology Hospital   (Italy)

^f UNIVERSITY OF BARI   (Italy)

^g ANMCO RESEARCH CENTER   (Italy)

^h Cardiovascular Prevention Center   (Italy)

Author keywords

albuminuria; chronic kidney disease; glomerular filtration rate; health survey; risk profile

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; SMOKING; URINE LEVEL; BLOOD; COMPLICATION; GEOGRAPHY; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

ADULT; AGED; CREATININE; FEMALE; GEOGRAPHY; GLOMERULAR FILTRATION RATE; HEALTH SURVEYS; HUMANS; HYPERTENSION; ITALY; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84929601133     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu383     Document Type: Article

References (41)

1. Jha V, Garcia-Garcia G, Iseki K et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382: 260-272
2. Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3: 1-150
3. Zoccali C, Kramer A, Jager KJ. Epidemiology of CKD in Europe: an uncertain scenario. Nephrol Dial Transplant 2010; 25: 1731-1733
4. McCullough K, Sharma P, Ali T et al. Measuring the population burden of chronic kidney disease: A systematic literature review of the estimated prevalence of impaired kidney function. Nephrol Dial Transplant 2012; 27: 1812-1821
5. Lozano R, Naghavi M, Foreman K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013; 380: 2095-2128
6. Hallan SI, Matsushita K, Sang Y et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 2012; 308: 2349-2360
7. Mahmoodi BK, Matsushita K, Woodward M et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: A meta-analysis. Lancet 2012; 380: 1649-1661
8. Fox CS, Matsushita K, Woodward M et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: A meta-analysis. Lancet 2012; 380: 1662-1673
9. Minutolo R, De Nicola L, Mazzaglia G et al. Detection and awareness of moderate to advanced CKD by primary care practitioners: A cross-sectional study from Italy. Am J Kidney Dis 2008; 52: 444-453
10. Tuot DS, Platinga LC, Hsu CY et al. Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction. Clin J Am Soc Nephrol 2011; 6: 1838-1844
11. Matsushita K, Mahmoodi BK,WoodwardMet al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012; 307: 1941-1951
12. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
13. Arora P, Vasa P, Brenner D et al. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 2013; 185: E417-E423
14. Zhang L, Wang F, Wang L et al. Prevalence of chronic kidney disease in China: A cross-sectional survey. Lancet 2012; 379: 815-822
15. White SL, Polkinghorne KR, Atkins RC et al. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: The AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. Am J Kidney Dis 2010; 55: 660-670.
16. De Zeeuw D, Hillege HL, de Jong PE. The kidney, a cardiovascular risk marker and a new target for therapy. Kidney Int 2005; 68(Suppl 98): S25-S29
17. Viktorsdottir O, Palsson R, Andresdottir MB et al. Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults. Nephrol Dial Transplant 2005; 20: 1799-1807
18. Hallan SI, Coresh J, Astor BC et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17: 2275-2284
19. Cirillo M, Laurenzi M, Mancini M et al. Low glomerular filtration in the population: prevalence, associated disorders, and awareness. Kidney Int 2006; 70: 800-806
20. Ponte B, Pruijm M, Marques-Vidal P et al. Determinants and burden of chronic kidney disease in the population-based CoLaus study: A crosssectional analysis. Nephrol Dial Transplant 2013; 28: 2329-2339
21. Van Biesen W, De Bacquer D, Verbeke F et al. The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years. Eur Heart J 2007; 28: 478-483
22. Otero A, de Francisco A, Gayoso P et al. Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrologia 2010; 30: 78-86
23. Gambaro G, Yabarek T, Graziani MS et al. Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. Clin J Am Soc Nephrol 2010; 5: 1946-1953
24. Giampaoli S, Palmieri L, Chiodini P et al. The global cardiovascular risk chart. Ital Heart J Suppl 2004; 5: 177-185
25. Tunstall-Pedoe H. Prepared by Tunstall-Pedoe H, Kuulasmaa K, Tolonen H, Davidson M, Mendis S with 64 other contributors for The WHO MONICA Project. MONICA Monograph and Multimedia Sourcebook. Geneva:World Health Organization, 2003. ISBN 92 4 156223 4
26. Heldal J, Jentoft S. Target population and sample size. In: H Tolonen (ed). EHES Manual: Part A: Planning and Preparation of the Survey. Helsinki: National Institute for Health and Welfare, 2013. http://urn.fi/URN:ISBN: 978-952-245-842-1
27. Radhakrishnan J, Remuzzi G, Saran R et al. Taming the chronic kidney disease epidemic: A global view of surveillance efforts. Kidney Int 2014; 86: 246-250
28. Cirillo M, Lanti MP, Menotti A et al. Definition of kidney dysfunction as a cardiovascular risk factor: use of urinary albumin excretion and estimated glomerular filtration rate. Arch Intern Med 2008; 168: 617-624
29. Marti F, Vollenweider P, Marques-Vidal PM et al. Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study. BMC Public Health 2011; 11: 733
30. Stengel B, Metzger M, Froissart M et al. Epidemiology and prognostic significance of chronic kidney disease in the elderly-The Three-City prospective cohort study. Nephrol Dial Transplant 2011; 26: 3286-3295
31. Grams ME, Chow EK, Segev DL et al. Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis 2013; 62: 245-252
32. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
33. Remuzzi G, Benigni A, Finkelstein FO et al. Kidney failure: aims for the next 10 years and barriers to success. Lancet 2013; 382: 353-362
34. Go AS, Mozaffarian D, Roger VL et al. Executive summary: heart disease and stroke statistics-2013 update: A report from the American Heart Association. Circulation 2013; 127: 143-152
35. Menotti A, Lanti M, Puddu PE et al. Coronary heart disease incidence in northern and southern European populations: A reanalysis of the seven countries study for a European coronary risk chart. Heart 2000; 84: 238-244
36. Yoshino M, Kuhlmann MK, Kotanko P et al. International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol 2006; 17: 3510-3519
37. van Dijk PC, Zwinderman AH, Dekker FW et al. Effect of general population mortality on the north-south mortality gradient in patients on replacement therapy in Europe. Kidney Int 2007; 71: 53-59
38. Estruch R, Ros E, Salas-Salvadó J et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368: 1279-1290
39. Huang X, Jiménez-Moleón JJ, Lindholm B et al. Mediterranean diet, kidney function, and mortality in men with CKD. Clin J Am Soc Nephrol 2013; 8: 1548-1555
40. da Silva R, Bach-Faig A, Raidó Quintana B et al. Worldwide variation of adherence to the Mediterranean diet, in 1961-1965 and 2000-2003. Public Health Nutr 2009; 12: 1676-1684
41. Murray CJL, Richards MA, Newton JN et al. UK health performance: findings of the Global Burden of Disease Study 2010. Lancet 2013; 381: 997-1020